Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 7 | 2018 | 691 | 0.930 |
Why?
|
| Brain Ischemia | 3 | 2018 | 159 | 0.920 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 3 | 2014 | 34 | 0.820 |
Why?
|
| Registries | 1 | 2018 | 294 | 0.500 |
Why?
|
| Neurology | 3 | 2013 | 50 | 0.470 |
Why?
|
| Histoplasmosis | 1 | 2015 | 2 | 0.450 |
Why?
|
| Vasculitis | 1 | 2015 | 26 | 0.450 |
Why?
|
| Cerebrovascular Disorders | 1 | 2014 | 51 | 0.420 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 67 | 0.410 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2013 | 8 | 0.390 |
Why?
|
| Cerebral Ventricles | 1 | 2013 | 13 | 0.390 |
Why?
|
| Mentors | 1 | 2013 | 33 | 0.390 |
Why?
|
| Intracranial Hypertension | 1 | 2013 | 19 | 0.390 |
Why?
|
| Internship and Residency | 2 | 2013 | 319 | 0.310 |
Why?
|
| HIV Infections | 1 | 2014 | 450 | 0.290 |
Why?
|
| Epinephrine | 1 | 2005 | 44 | 0.220 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2005 | 43 | 0.220 |
Why?
|
| Cerebral Hemorrhage | 1 | 2005 | 72 | 0.220 |
Why?
|
| Aspirin | 2 | 2008 | 59 | 0.190 |
Why?
|
| Carotid Stenosis | 2 | 2002 | 59 | 0.180 |
Why?
|
| Ophthalmic Artery | 1 | 2002 | 9 | 0.180 |
Why?
|
| Humans | 15 | 2018 | 32284 | 0.180 |
Why?
|
| Male | 8 | 2018 | 19443 | 0.150 |
Why?
|
| Brain Infarction | 1 | 2018 | 10 | 0.140 |
Why?
|
| Fibrinolytic Agents | 1 | 2008 | 63 | 0.140 |
Why?
|
| Clinical Competence | 3 | 2005 | 330 | 0.130 |
Why?
|
| Coronary Disease | 1 | 2008 | 226 | 0.130 |
Why?
|
| Students, Medical | 3 | 2014 | 126 | 0.120 |
Why?
|
| Middle Aged | 6 | 2015 | 11853 | 0.110 |
Why?
|
| Aged | 6 | 2018 | 10265 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2018 | 3628 | 0.110 |
Why?
|
| Multimedia | 2 | 2005 | 19 | 0.110 |
Why?
|
| Patient Simulation | 2 | 2005 | 29 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 504 | 0.110 |
Why?
|
| Female | 8 | 2018 | 19947 | 0.100 |
Why?
|
| Curriculum | 2 | 2014 | 203 | 0.100 |
Why?
|
| Information Storage and Retrieval | 1 | 2014 | 26 | 0.100 |
Why?
|
| Computer Simulation | 2 | 2005 | 251 | 0.100 |
Why?
|
| Patient Readmission | 1 | 2014 | 135 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 3902 | 0.100 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2011 | 42 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 1224 | 0.080 |
Why?
|
| Risk Reduction Behavior | 1 | 2011 | 117 | 0.080 |
Why?
|
| Brain | 2 | 2015 | 965 | 0.080 |
Why?
|
| Adipose Tissue | 1 | 2011 | 320 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2013 | 3416 | 0.070 |
Why?
|
| Administration, Inhalation | 1 | 2005 | 43 | 0.060 |
Why?
|
| Spinal Puncture | 1 | 2005 | 22 | 0.060 |
Why?
|
| Medical Staff, Hospital | 1 | 2005 | 19 | 0.060 |
Why?
|
| Thalamus | 1 | 2005 | 36 | 0.060 |
Why?
|
| Ticlopidine | 1 | 2004 | 12 | 0.050 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2005 | 75 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2004 | 79 | 0.050 |
Why?
|
| Obesity | 1 | 2011 | 1111 | 0.050 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2003 | 5 | 0.050 |
Why?
|
| Ischemic Attack, Transient | 1 | 2004 | 57 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 1437 | 0.050 |
Why?
|
| Hemorrhage | 2 | 2008 | 95 | 0.050 |
Why?
|
| Anterior Cerebral Artery | 1 | 2002 | 2 | 0.050 |
Why?
|
| Brachiocephalic Trunk | 1 | 2002 | 4 | 0.050 |
Why?
|
| Collateral Circulation | 1 | 2002 | 10 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2002 | 17 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2002 | 50 | 0.040 |
Why?
|
| Adult | 1 | 2014 | 9259 | 0.040 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2002 | 37 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2002 | 78 | 0.040 |
Why?
|
| Cerebral Angiography | 1 | 2002 | 60 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 287 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 907 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 556 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 2 | 2014 | 34 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 883 | 0.040 |
Why?
|
| Cause of Death | 1 | 2008 | 236 | 0.030 |
Why?
|
| Risk Factors | 2 | 2004 | 3934 | 0.030 |
Why?
|
| Florida | 2 | 2005 | 42 | 0.030 |
Why?
|
| Librarians | 1 | 2014 | 3 | 0.030 |
Why?
|
| Problem-Based Learning | 1 | 2014 | 29 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 61 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2014 | 171 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2005 | 757 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 854 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 757 | 0.020 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2011 | 22 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 853 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2011 | 65 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 273 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2011 | 181 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2011 | 120 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 1534 | 0.020 |
Why?
|
| Adiposity | 1 | 2011 | 190 | 0.020 |
Why?
|
| Diet | 1 | 2011 | 383 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2011 | 484 | 0.020 |
Why?
|
| Weight Loss | 1 | 2011 | 410 | 0.020 |
Why?
|
| Exercise | 1 | 2011 | 603 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 2205 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 27 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 292 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 285 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2003 | 75 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2004 | 565 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2003 | 113 | 0.010 |
Why?
|
| United States | 1 | 2011 | 4072 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2002 | 164 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2005 | 2316 | 0.010 |
Why?
|